Breaking News

Astrea Bioseparations Invests in Critical Infrastructure in UK and Singapore

Also appoints Dr. Claire Dacombe as vice president of Asia Pacific Operations.

Author Image

By: Charlie Sternberg

Associate Editor

Astrea Bioseparations has made two new investments to enhance operations and customer support resources. The investments include an expansion of the company’s research and development facility in Cambridge, United Kingdom to add two new laboratories. Separately, a branch office was registered in Singapore to serve customers in Asia with Claire Dacombe, PhD appointed as vice president of Asia Pacific Operations.   “The Cambridge laboratory expansion was a first step in bolstering capacity to meet...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters